Orthobiologics Market to Reach US$ 8261.6 Mn by 2026, Growing Patient Awareness Drives Market | Fortune Business Insights

The global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The Global Orthobiologics Market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Orthobiologics Market is likely to gain traction on account of rising geriatric population, which in turn is indicative of the increasing prevalence of chronic arthritis. Fortune Business Insights published a report, titled “Orthobiologics Market Size, Share and Global Trend by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics) and Geography Forecast till 2025” which offers valuable insights into the drivers positively impacting the global market.

As per this report, the global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The global orthobiologics market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/orthobiologics-marke-100173

Demand for Spinal Fusion Method Expected to Increase

A lead analyst at Fortune Business Insights said, “Spinal fusion covered the highest share in the global orthobiologics market in 2018 owing to the rising prevalence of traumatic injuries and accidents.” “The advantages offered by orthobiologics regarding the treatment of spine-related injuries may fuel the demand for spinal fusion method,” he continued. Another application called soft tissue repair is anticipated to witness the highest growth on account of escalating demand for orthobiologics in cartilage repair. Rising incidence of sports injuries is also responsible for driving the soft tissue repair segment.

Favorable Reimbursement Policies Supports Growth in North America

From a geographical standpoint, North America is expected to lead the global orthobiologics market between 2028 and 2026. In 2018, the market for orthobiologics in North America has valued at US$ 2326.2 Mn. Favourable reimbursement policies in the U.S. and rising adoption of advanced orthobiologics therapies are key factors contributing to the market’s growth in the region. The rising demand for a better quality healthcare in North America is also expected to create growth opportunities for the orthobiologics market in the region. Trailing North America, Europe is the second most prominent region, covering a significant share in the global market for orthobiologics. Growth of the orthobiologics market in Europe is attributable to recent FDA approvals for orthobiologics products. The rising demand for viscosupplements and increasing number of orthopaedic clinics are factors driving the orthobiologics market in Asia Pacific.

BioFiber by Tornier and Similar Product Developments to Boost Growth

The global orthobiologics market is driven by emerging technologies in orthobiologics treatment. For instance, a technology called 3D printed implant offers better stability and significantly reduces surgery time. A global leader in orthopaedics called Tornier has launched BioFiber Surgical Mesh. This technology helps to repair ligament injuries and other muscle injuries. Growing geriatric population is another factor fuelling demand for orthobiologics products such as orthobiologics injections. The rising clearances for several orthobiologics products is driving the orthobiologics market during the forecast period. Other factors likely to boost the orthobiologics market include increasing demand for advanced treatment and high growth potential especially in emerging countries.

Stringent Regulations and High Cost May Restrict the Market to Grow

Although the orthobiologics market is growing considerably, there are some factors that may hamper the growth. These include high costs associated with orthobiologics treatment. People in low-income regions cannot afford such treatments and this may pose a serious threat to the growth of the orthobiologics market. Another factor hampering the market is strict approval process for orthobiologics treatment and products.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/orthobiologics-marke-100173

NuVasive’s Launch of Propel DBM in 2018, to Boost its Market Position

Some of the leading players presently operating in the global orthobiologics market are Medtronic, Stryker, Sanofi, Zimmer Biomet, Bioventus, Sea Spine, Musculoskeletal Transplant Foundation, Wright Medical Group N.V., and RTI Surgical Holdings, Inc. Companies are focussing on launching new and technologically advanced orthobiologic products to increase their share in the orthobiologics market. For instance, NuVasive announced the launch of a new product called Propel DBM in 2018. This product helps to encourage bone growth among patients suffering from bone disorders.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/orthobiologics-market-to-reach-us-82616-mn-by-2026-growing-patient-awareness-drives-market-fortune-business-insights/513471

Source: MarketersMedia

Release ID: 513471

Latest News

VW, Ford team up to make autonomous, electric vehicles

Jul 17, 2019

NEW YORK — Volkswagen will invest $2.6 billion into a Pittsburgh autonomous vehicle company that's mostly owned by Ford as the automakers who were once rivals deepen their partnership to develop driverless and electric vehicles in an ultra-competitive landscape. The two automakers will become equal owners of Argo AI, and they plan to put autonomous vehicles on the roads in the U.S. and Europe as early as 2021, the companies said Friday. The deal also includes a plan for Ford to use VW's electric vehicle platform to build zero-emissions cars for the European market starting in 2023. Auto companies have...

The Latest: Experts like what they see in Ford, VW tie-up

Jul 17, 2019

NEW YORK — The Latest on Ford's alliance with Volkswagen (all times local): 9:25 a.m. Auto industry watchers say Ford and Volkswagen have the right idea with their new partnership to develop autonomous and electronic vehicle technology. The companies on Friday announced Friday that Volkswagen will invest $2.6 billion into a Pittsburgh autonomous vehicle company that's mostly owned by Ford. Jessica Caldwell, executive director industry insights for the Edmunds.com auto pricing site, says the deal should help both companies and is an example of what's needed in the business to share enormous capital costs. She says both automakers are facing...

Trump applauds far-right social media provocateurs

Jul 17, 2019

WASHINGTON — President Donald Trump used a White House conference Thursday to applaud far-right social media provocateurs even as he conceded that some of them are extreme in their views. Trump, who has weaponized social media to eviscerate opponents and promote himself, led a "social media summit" of like-minded critics of Big Tech, excluding representatives from the very platforms he exploits. The president used the event to air grievances over his treatment by Big Tech, but also to praise some of the most caustic voices on the right, who help energize Trump's political base. "Some of you guys are out...

Fresh from the lab: Startups make meat that avoids slaughter

Jul 17, 2019

EMERYVILLE, Calif. — Uma Valeti slices into a pan-fried chicken cutlet in the kitchen of his startup, Memphis Meats. He sniffs the tender morsel on his fork before taking a bite. He chews slowly, absorbing the taste. "Our chicken is chicken ... you've got to taste it to believe it," Valeti says. This is no ordinary piece of poultry. No chicken was raised or slaughtered to harvest the meat. It was produced in a laboratory by extracting cells from a chicken and feeding them in a nutrient broth until the cell culture grew into raw meat. Memphis Meats, based in...

Oklahoma judge denies motion to end case against drugmaker

Jul 17, 2019

OKLAHOMA CITY — An Oklahoma judge decided Monday the state's ongoing opioid drug lawsuit against consumer products giant Johnson & Johnson can move forward, rejecting the company's argument that the state failed to prove its public-nuisance claim. District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favor of the New Brunswick, New Jersey-based company and its subsidiaries, including Janssen Pharmaceuticals Inc. The defendants filed the motion last week after the state rested its case. The trial began May 28. Company attorneys had argued the state's case is an inappropriate...

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!